top signin

Pin It

interior-banner-mask

.

Press 2019

Dec 03, 2019

Biostage Receives Response from the FDA for Investigational New Drug Application...

  HOLLISTON, Mass., Dec. 3, 2019 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal implants, today announced that it...


Nov 12, 2019

Biostage Reports Third Quarter 2019 Financial Results...

HOLLISTON, Mass., Nov. 12, 2019 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG), a bioengineering company developing next-generation esophageal implants, today announced its financial results for the three and...


Nov 06, 2019

Biostage to Host Conference Call to Discuss Third Quarter 2019 Financial Results...

- Conference Call with Live Audio Webcast on Tuesday November 12th at 9:00 AM ET -   HOLLISTON, Mass., Nov. 6, 2019 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG), a bioengineering company developing...


Oct 30, 2019

Biostage Submits Investigational New Drug (IND) Application for Lead Product Can...

  HOLLISTON, Mass., Oct. 30, 2019 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG), a bioengineering company developing next-generation esophageal implants, today announced it has submitted an...


Aug 13, 2019

Biostage Reports Second Quarter 2019 Financial Results...

-- Preparing to file first IND in September 2019   HOLLISTON, Mass., Aug. 13, 2019 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a biotechnology company developing...


Aug 07, 2019

Biostage to Host Conference Call to Discuss Second Quarter 2019 Financial Result...

- Conference Call with Live Audio Webcast on Tuesday August 13th at 9:00 AM ET -   HOLLISTON, Mass., Aug. 7, 2019 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing...


May 14, 2019

Biostage Reports First Quarter 2019 Financial Results...

- Preparing to file first IND in Q3 2019   HOLLISTON, Mass., May 14, 2019 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a biotechnology company developing bioengineered...


May 08, 2019

Biostage to Host Conference Call to Discuss First Quarter 2019 Financial Results...

- Conference Call with Live Audio Webcast on Tuesday May 14th at 9:00 AM ET -   HOLLISTON, Mass., May 8, 2019 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing...


Mar 28, 2019

Biostage Reports 2018 Financial Results...

- Pre-clinical and human compassionate use clinical evidence support IND filing mid-year 2019   HOLLISTON, Mass., March 28, 2019 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the...


Mar 21, 2019

Biostage to Host Conference Call to Discuss 2018 Financial Results and Business ...

- Conference Call with Live Audio Webcast on Thursday March 28th at 9:00 AM ET -   HOLLISTON, Mass., March 21, 2019 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing...


Jan 28, 2019

First-In-Human Case Using Biostage's Bioengineered Esophageal Implant is Present...

  HOLLISTON, Mass., Jan. 28, 2019 /PRNewswire/ -- Dennis Wigle, M.D., Ph.D, chair of thoracic surgery at Mayo Clinic in Rochester, Minnesota, speaking at the Society of Thoracic Surgeons Tech-Con 2019...